skip to main content

    Updated Visitor Guidelines

 

MENU

 

Structure and Drug Screening

Project-Specific Entry Points for Structure and Drug Screening Resources

Service Highlights

  • Single entry point for technical expertise and equipment for using in academic drug discovery
  • Creation and execution of translational cancer drug discovery project plans that start with the end in mind
  • Cost savings due to streamlined structure and execution
  • Expert consulting in structural biology, target/pathway identification, protein production, and assay development

Health Communications

Service Highlights

  • Offers support from a multi-disciplinary team of:
    • Behavioral and communication scientists
    • Designers
    • Technology developers
  • No-cost consultation study design
  • Manuscript and grant preparation/execution
  • Prototype design and development
  • Deployment of research investigation
  • Maintenance and dissemination of evidence-based health communications programs

Flow Cytometry

Service Highlights

  • Offers state-of-the-art cell sorting, cell analysis, and image cytometry analysis
  • BSL2+ sorting capacity in all three facilities
  • Assistance in grant and publication preparation and publication-quality graphics
  • Data analysis and graphical representations for publication and grants
  • Free project consultation and optimization with the director/managing director
  • 25% discount to Rogel Cancer Center members (subject to a $2,000 per lab cap)

Experimental Irradiation

Announcing Small Animal Radiation Research Platform (SARRP)

Cancer Data Science

The overarching goals of CDS are to provide assistance to Rogel Cancer Center investigators in all quantitative aspects of cancer research

Virtual office hours

Contact Us

To request assistance, please fill out this form: Project Intake Form

For more information about CDS, please contact our team:

New finding offers clues for blocking cancer gene

A new study suggests a potential new way to block one of the most common cancer-causing genes, without causing severe side effects.

Breast Cancer Advisory and Advocacy Group

Due to the COVID-19 pandemic, groups have not been meeting in person. For information about our patient-focused virtual groups, please see our Patient and Family Events Calendar.

Tool helps patients, providers decide if lung cancer screening is warranted

A new study shows that a web-based app is effective at improving patient's knowledge about lung cancer and screening. The app offers personalized recommendations to help people determine if they are right for lung cancer screening.

Research explains limits of cancer immunotherapy drugs

A new study from the University of Michigan Rogel Cancer Center reveals molecular changes within a tumor that are preventing immunotherapy drugs from killing off the cancer. It explains why not all patients respond to immunotherapy treatments.

Pages